Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial

Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the study record, and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.5%
    Check dated 2026-10-21T00:46:16.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.0 to v3.7.1; the study record content is unchanged.
    Difference
    0.1%
    Check dated 2026-10-07T01:03:53.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.7.0 and removes the earlier v3.6.6 entry, updating the version history.
    Difference
    0.1%
    Check dated 2026-09-16T00:06:52.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.6.6 was added to the history, replacing Revision: v3.6.5 and indicating an update to the record.
    Difference
    0.1%
    Check dated 2026-09-01T20:01:23.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.6.5 now appears on the page, replacing v3.6.4 and signaling an updated site build for the Record History view.
    Difference
    0.1%
    Check dated 2026-08-11T15:24:30.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The revision label on the study record history was updated from v3.6.3 to v3.6.4 to reflect a new site release.
    Difference
    0.1%
    Check dated 2026-07-28T04:59:04.000Z thumbnail image

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.